Current Infectious Disease Reports

, Volume 2, Issue 3, pp 193–200

Nontuberculous mycobacterial infections of the lung

  • Irene S. Kourbeti
  • Melanie J. Maslow
Article

DOI: 10.1007/s11908-000-0035-7

Cite this article as:
Kourbeti, I.S. & Maslow, M.J. Curr Infect Dis Rep (2000) 2: 193. doi:10.1007/s11908-000-0035-7

Abstract

There is an increasing appreciation for the role of nontuberculous mycobacteria (NTM) as pathogens causing pulmonary disease, disseminated disease, or both in immunocompetent and immunocompromised individuals. Species previously considered nonpathogenic have been shown to cause pulmonary infection. The majority of immunocompetent patients with NTM pulmonary infection have underlying lung disease. New diagnostic techniques such as gene probes, gas-liquid and high-pressure chromatography, and polymerase chain reaction offer significant advantages in the rapid identification of NTM species. Some of these techniques allow identification of mycobacteria directly from clinical specimens. The fluoroquinolones, rifabutin, and newer macrolides offer advances in the treatment of infections that are caused by NTM and are resistant to the traditional antimycobacterial drugs.

Copyright information

© Current Science Inc 2000

Authors and Affiliations

  • Irene S. Kourbeti
    • 1
  • Melanie J. Maslow
    • 1
  1. 1.Infectious Diseases Section, VA-New York Harbor Health Care System and the Department of Internal MedicineNew York University School of MedicineNew YorkUSA

Personalised recommendations